Scoring atopic dermatitis in infants and young children: Distinctive features of the SCORAD index

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 60, Issue 1, 2005, Pages 113-116

  Pucci, Neri ^a   Novembre, E ^a   Cammarata, M G ^b   Bernardini, R ^a   Monaco, M G ^a   Calogero, C ^a   Vierucci, A ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b S ANNA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATOPIC DERMATITIS; BODY DISTRIBUTION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; EDEMA; ERYTHEMA; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PAPULE; PARAMETER; PRESCHOOL CHILD; PRIORITY JOURNAL; SCORAD INDEX; SCORING SYSTEM; SKIN MANIFESTATION;

CHILD, PRESCHOOL; DERMATITIS, ATOPIC; EDEMA; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL-DERIVED NEUROTOXIN; ERYTHEMA; HUMANS; INFANT; SEVERITY OF ILLNESS INDEX;

EID: 12444281723     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2004.00622.x     Document Type: Article

References (15)

1. Leung DY, Bieber T. Atopic dermatitis. Lancet 2003;361:151-160.
2. Gustafsson D, Sjoberg O, Foucard T. Development of allergies and asthma in infants and young children with atopic dermatitis - a prospective follow-up to 7 years of age. Allergy 2000;55:240-245.
3. European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the SCORAD index. Dermatology 1993;186:23-31.
4. Sprikkelman AB, Tupker RA, Burgerhof H, Schouten JP, Brand PLP, Heymans HSA et al. Severity scoring of atopic dermatitis: a comparison of three scoring systems. Allergy 1997;52:944-949.
5. Kunz B, Oranje AP, Labrèze L, Stalder JF, Ring J, Taïeb A. Clinical Validation and guidelines for the SCORAD index: consensus report of the European Task Force on atopic dermatitis. Dermatology 1997;195:10-19.
6. Charman C, Williams H. Outcome measures of disease severity in atopic eczema. Arch Dermatol 2000;136:763-769.
7. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Dermatol Venereol 1980;92:44-47.
8. Pucci N, Lombardi E, Novembre E, Farina S, Bernardini R, Rossi ME et al. Urinary eosinophil protein X and serum eosinophil cationic protein in infants and young children with atopic dermatitis: correlation with disease activity. J Allergy Clin Immunol 2000;105:353-357.
9. Kristjánsson S, Strannegård IL, Strannegård Ö, Peterson C, Enander I, Wennergren G. Urinary eosinophil protein X in children with atopic asthma: a useful marker of anti-inflammatory treatment. J Allergy Clin Immunol 1996;97:1179-1187.
10. Sugiura H, Umemoto N, Deguchi H, Murata Y, Tanaka K, Sawai T et al. Prevalence of childhood and adolescent atopic dermatitis in a Japanese population: comparison with the disease frequency examined 20 years ago. Acta Derm Venereol 1998;78:293-294.
11. Linna O, Kokkonem J, Lahtelòa P, Tammela O. Ten-year prognosis for generalized infantile eczema. Acta Pediatr 1992;81:1013-1016.
12. Kissling S, Wuthrich B. Sites, types of manifestations and micromanifestations of atopic dermatitis in young adults: a personal follow-up 20 years after diagnosis in childhood. Hautarz 1994;45:368-371.
13. Oranje AP, Stalder JE, Taieb A, Tasset C, DE Longueville M. Sxcorig of atopic dermatitis by SCORAD using a training atlas by investigators from different disciplines. Pediatr Allergy Immunol 1997;8:28-34.
14. Sugarman JL, Fluhr JW, Fowler AJ, Bruckner T, Diepgen TL, Williams ML. The objective severity assessment of atopic dermatitis score. Arch Dermatol 2003;139:1417-1422.
15. Breuer K, Kapp A, Werfel T. Urine eosinophil protein X (EPX) is an in vitro parameter of inflammation in atopic dermatitis of the adult age. Allergy 2001;56:780-784.